Hypoxic gene signatures are prevalent in paediatric rhabdomyosarcomas and are important in conferring resistance to standard treatments. Oxygen-enhanced MRI (OE-MRI) and histological assessment of pimonidazole adduct formation show that xenografts derived from three human rhabdomyosarcoma cell lines exhibit high levels of hypoxia with differences in vascular perfusion evident between the models.
There is much interest in hypoxia-alleviating strategies to reduce tumour hypoxia for therapeutic gain, and these will be assessed in rhabdomyosarcoma models in vivo using OE-MRI. A reduction in hypoxia in response to atovaquone in spheroids derived from the same rhabdomyosarcoma cell lines in vitro has been confirmed.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords